Swasthya Adhikar Manch

Swasthya Adhikar Manch is a nonprofit organization in India which advocates for safety in clinical trials.

A women's branch advocated for health safety.[1]

Amulya Nidhi has said that pharma companies wish to avoid all regulation of their research, and because of this, people have to advocate for themselves.[2]

The organization filed a public interest litigation in 2012 asking for government intervention.[3] That petition became Swasthya Adhikar Manch v. Union of India, a court case. The Supreme Court of India sided with the organization in 2013 on a case about clinical trial safety.[4] In response, the government halted approval of new clinical trials until regulation was in place.[5]

The organization has made some progress in improving safety of clinical trials.[6]

In 2020 the organization commented that despite advances, transparency of health research information for the research participant is still not a common practice.[7]

References
  1. Balestra, Giulietta Luul; Dasgupta, Jashodhara; Sandhya, Yatirajula Kanaka; Mannell, Jenevieve (2 December 2018). "Developing political capabilities with Community-Based Monitoring for health accountability: The case of the Mahila Swasthya Adhikar Manch". Global Public Health. 13 (12): 1853–1864. doi:10.1080/17441692.2018.1464586. PMID 29671373. S2CID 5001036.
  2. GOI Monitor Desk (3 January 2015). "Pharma companies don't want any regulation". Goi Monitor.
  3. Shelar, Jyoti (2 June 2018). "After a lull of five years, clinical trials on the rise in India". The Hindu.
  4. Kay, M. (3 July 2014). "Indian Supreme Court demands clarity on clinical trial approvals". BMJ. 349 (jul03 13): g4383. doi:10.1136/bmj.g4383. PMID 24994706. S2CID 37807701.
  5. Bagcchi, S. (4 October 2013). "Indian Supreme Court halts approval of new clinical trials until regulatory framework is set up". BMJ. 347 (oct04 2): f5996. doi:10.1136/bmj.f5996. PMID 24097130. S2CID 43077030.
  6. Srinivasan, Sandhya (17 April 2016). "Trials and tribulations". Himal Southasian.
  7. Datta, PT Jyothi (17 January 2020). "It has been a defining decade for clinical trials". Business Line.
  • Archived 7 May 2015 at the Wayback Machine
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.